Sound Capital Solutions’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,913
Closed -$710K – 318
2026
Q2
$710K Buy
+23,913
New +$534K 0.17% 76

Other funds holding BCAX

Sound Capital Solutions's BCAX Position: Q3 2026 in Review

Sound Capital Solutions sold out of Bicara Therapeutics (BCAX) in Q3 2026, closing a stake of 23,913 shares — an estimated $710K sold.

Sound Capital Solutions first reported a position in BCAX in Q2 2026 and held it in 1 quarter. The position peaked at $710K in Q2 2026. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Sound Capital Solutions reported no remaining Bicara Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Sound Capital Solutions sold 23,913 Bicara Therapeutics shares in Q3 2026, an estimated $710K.
  • Sound Capital Solutions first reported a position in Bicara Therapeutics in Q2 2026 and held it in 1 quarter.
  • Sound Capital Solutions's Bicara Therapeutics position peaked at $710K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Sound Capital Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.